Food Safety

Canadian marketing approval received on DNA IHNV virus vaccine for salmon

Published in Medical Letter on the CDC and FDA, August 21st, 2005

Vical Incorporated, (VICL) announced that its licensee Aqua Health Ltd. of Canada, an affiliate of the Swiss-based company Novartis Animal Health, received notification of approval from the Canadian Food Inspection Agency (CFIA) to sell APEX-IHN, a DNA vaccine, to protect farm-raised salmon against infectious hematopoietic necrosis virus (IHNV).

This vaccine has previously been available on a pre-approval basis in support of extensive field trials.

IHNV is a virus that affects both multiple species of wild and farm-raised salmon. The disease is endemic in the Pacific North West in wild salmon populations, which has been a source of infection for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2005-08-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry